Statistics
Publications
24
Citations
3.6K
H-Index
22
Active since
2006
Daniel Ho is an author at Novartis (Switzerland) specializing in life sciences, molecular neuroscience, and neuroscience.
Publications per year
2006–2023
24
24
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 1K citations
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Chaoyang Ye, Daniel Ho, Marilisa Neri et al. · Nature Communications · 2018 · 238 citations · Full text
<i>PIK3CA</i> Mutations in Head and Neck Squamous Cell Carcinoma
Wanglong Qiu, Frank Schönleben, Xiaojun Li et al. · Clinical Cancer Research · 2006 · 201 citations · Full text
1–5 of 24